Inhibition of fusidic acid resistance through restricting conformational flexibility in domain III of EF-G
Fusidic acid (FA) is one of few remaining antibiotics active against Methicillin-resistant <i>Staphylococcus aureus</i>. FusB confers resistance to FA by rescuing the translocation factor Elongation Factor-G (EF-G) from FA-stalled ribosome complexes. FusB induces allosteric effects on dynamics in EF-G, causing significant changes in the conformational flexibility of domain III that result in an increase in a minor, more disordered state, overcoming the steric block induced by FA. We show that restraining flexibility in the two central β-strands of EF-G domain III prevents the FusB-induced increase in this minor state population, preventing FusB-mediated release of EF-G from the ribosome and thereby reinstating FA-induced stalling of protein synthesis. We further identify a region controlling access to the minor state population, potentially pinpointing the allosteric mechanism within domain III by which FusB acts. Our findings suggest a possible region that could be targeted for rational design of an inhibitor of FusB-mediated conformational flexibility, reinstating FA sensitivity even in the presence of FusB, which could rejuvenate the efficacy of this clinically important antibiotic.
Authors
- Alexandra Schindl (ORCID: https://orcid.org/0009-0002-5154-7842)
- Arnout P. Kalverda
- Antonio N. Calabrese (ORCID: https://orcid.org/0000-0003-2437-7761)
- Jennifer H. Tomlinson (ORCID: https://orcid.org/0000-0003-4081-5055)
- Gemma C. Wildsmith
- Leela Ghimire (ORCID: https://orcid.org/0009-0006-7026-6308)
- Megan Jones (ORCID: https://orcid.org/0009-0001-4325-3505)
Institutions
- University of Leeds (GB)
- Institute of Structural and Molecular Biology (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1073/pnas.2508779122
- Primary Topic
- RNA and protein synthesis mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Francis Crick Institute
- Cancer Research UK
- University of Leeds
- National Institutes of Health
- Directorate for Biological Sciences
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- National Institute of General Medical Sciences